Ameet Mallik - Articles and news items

Sandoz launches Phase III clinical trial for biosimilar etanercept

Industry news, News / 24 June 2013 / Novartis

Sandoz has initiated a major Phase III clinical trial with its biosimilar version of etanercept (Amgen’s Enbrel®)…

Sandoz initiates two more Phase III biosimilar trials, reinforcing long-term global leadership commitment

Industry news, News / 19 January 2012 / Novartis

Sandoz announced that it has initiated two milestone Phase III clinical trials…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+